Novavax, Inc. (NVV1.F)
EUR 5.7
(-3.99%)
EUR 5.7
(-3.99%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -545.06 Million USD | 19.67% |
| 2022 | -614.75 Million USD | 59.93% |
| 2021 | -1.53 Billion USD | -348.78% |
| 2020 | -341.84 Million USD | -189.17% |
| 2019 | -118.21 Million USD | 26.85% |
| 2018 | -161.61 Million USD | -5.6% |
| 2017 | -153.03 Million USD | 42.34% |
| 2016 | -265.43 Million USD | -83.73% |
| 2015 | -144.46 Million USD | -110.76% |
| 2014 | -68.54 Million USD | -81.71% |
| 2013 | -37.72 Million USD | -74.47% |
| 2012 | -21.62 Million USD | -44.96% |
| 2011 | -14.91 Million USD | 43.96% |
| 2010 | -26.61 Million USD | 0.48% |
| 2009 | -26.74 Million USD | -3.13% |
| 2008 | -25.93 Million USD | -9.06% |
| 2007 | -23.77 Million USD | -35.93% |
| 2006 | -17.49 Million USD | -84.67% |
| 2005 | -9.47 Million USD | 50.32% |
| 2004 | -19.06 Million USD | -10.4% |
| 2003 | -17.27 Million USD | 23.9% |
| 2002 | -22.69 Million USD | -132.91% |
| 2001 | -9.74 Million USD | 20.06% |
| 2000 | -12.19 Million USD | -170.91% |
| 1999 | -4.5 Million USD | 6.25% |
| 1998 | -4.8 Million USD | -6.67% |
| 1997 | -4.5 Million USD | 18.18% |
| 1996 | -5.5 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 162.38 Million USD | 218.75% |
| 2024 Q1 | -136.74 Million USD | 15.39% |
| 2023 Q4 | -161.62 Million USD | -30.64% |
| 2023 Q3 | -123.71 Million USD | -313.27% |
| 2023 Q2 | 58 Million USD | 121.39% |
| 2023 Q1 | -271.17 Million USD | -59.25% |
| 2023 FY | -493.83 Million USD | 19.67% |
| 2022 Q3 | -172.04 Million USD | 64.68% |
| 2022 FY | -614.75 Million USD | 59.93% |
| 2022 Q1 | 183.82 Million USD | 124.69% |
| 2022 Q2 | -487.1 Million USD | -364.99% |
| 2022 Q4 | -170.28 Million USD | 1.02% |
| 2021 Q1 | -189.49 Million USD | -30.58% |
| 2021 Q3 | -278.44 Million USD | 6.28% |
| 2021 Q2 | -297.08 Million USD | -56.77% |
| 2021 FY | -1.53 Billion USD | -348.78% |
| 2021 Q4 | -744.54 Million USD | -167.4% |
| 2020 FY | -341.84 Million USD | -189.17% |
| 2020 Q2 | -15.59 Million USD | 33.82% |
| 2020 Q3 | -168.25 Million USD | -978.6% |
| 2020 Q4 | -145.12 Million USD | 13.75% |
| 2020 Q1 | -23.57 Million USD | 16.87% |
| 2019 Q2 | -34.77 Million USD | 9.65% |
| 2019 FY | -118.21 Million USD | 26.85% |
| 2019 Q4 | -28.35 Million USD | -71.34% |
| 2019 Q1 | -38.48 Million USD | 10.81% |
| 2019 Q3 | -16.55 Million USD | 52.41% |
| 2018 FY | -161.61 Million USD | -5.6% |
| 2018 Q4 | -43.15 Million USD | -12.47% |
| 2018 Q3 | -38.37 Million USD | -0.7% |
| 2018 Q2 | -38.1 Million USD | -1.11% |
| 2018 Q1 | -37.68 Million USD | 10.99% |
| 2017 Q4 | -42.34 Million USD | -12.21% |
| 2017 Q1 | -41 Million USD | 24.27% |
| 2017 FY | -153.03 Million USD | 42.34% |
| 2017 Q2 | -38.98 Million USD | 4.92% |
| 2017 Q3 | -37.73 Million USD | 3.21% |
| 2016 FY | -265.43 Million USD | -83.73% |
| 2016 Q3 | -58.95 Million USD | 25.7% |
| 2016 Q2 | -79.35 Million USD | -2.72% |
| 2016 Q4 | -54.14 Million USD | 8.16% |
| 2016 Q1 | -77.25 Million USD | 1.97% |
| 2015 Q2 | -20.64 Million USD | 15.3% |
| 2015 FY | -144.46 Million USD | -110.76% |
| 2015 Q4 | -78.8 Million USD | -137.94% |
| 2015 Q1 | -24.37 Million USD | 22.75% |
| 2015 Q3 | -33.12 Million USD | -60.46% |
| 2014 Q2 | -17.86 Million USD | -29.36% |
| 2014 Q3 | -19.72 Million USD | -10.43% |
| 2014 FY | -68.54 Million USD | -81.71% |
| 2014 Q4 | -31.54 Million USD | -59.91% |
| 2014 Q1 | -13.81 Million USD | 1.74% |
| 2013 Q3 | -15.3 Million USD | -21.11% |
| 2013 FY | -37.72 Million USD | -74.47% |
| 2013 Q2 | -12.63 Million USD | -26.38% |
| 2013 Q1 | -9.99 Million USD | -24.41% |
| 2013 Q4 | -14.05 Million USD | 8.14% |
| 2012 FY | -21.62 Million USD | -44.96% |
| 2012 Q4 | -8.03 Million USD | -11.33% |
| 2012 Q2 | -5.92 Million USD | 19.3% |
| 2012 Q1 | -7.33 Million USD | -98.0% |
| 2012 Q3 | -7.21 Million USD | -21.91% |
| 2011 Q1 | -7.45 Million USD | -65.11% |
| 2011 FY | -14.91 Million USD | 43.96% |
| 2011 Q4 | -3.7 Million USD | -15.35% |
| 2011 Q3 | -3.21 Million USD | 35.67% |
| 2011 Q2 | -4.99 Million USD | 33.01% |
| 2010 Q3 | -10.35 Million USD | -9.86% |
| 2010 Q2 | -9.42 Million USD | 17.4% |
| 2010 Q4 | -4.51 Million USD | 56.41% |
| 2010 Q1 | -11.41 Million USD | 18.22% |
| 2010 FY | -26.61 Million USD | 0.48% |
| 2009 Q2 | -8.54 Million USD | -2.29% |
| 2009 Q1 | -8.34 Million USD | 24.65% |
| 2009 FY | -26.74 Million USD | -3.13% |
| 2009 Q4 | -13.95 Million USD | -85.33% |
| 2009 Q3 | -7.53 Million USD | 11.83% |
| 2008 Q2 | -9.37 Million USD | -20.85% |
| 2008 Q1 | -7.75 Million USD | 15.86% |
| 2008 FY | -25.93 Million USD | -9.06% |
| 2008 Q3 | -7.84 Million USD | 16.33% |
| 2008 Q4 | -11.08 Million USD | -41.29% |
| 2007 Q4 | -9.21 Million USD | -2.8% |
| 2007 Q3 | -8.96 Million USD | -9.42% |
| 2007 Q2 | -8.19 Million USD | 2.31% |
| 2007 Q1 | -8.38 Million USD | -36.43% |
| 2007 FY | -23.77 Million USD | -35.93% |
| 2006 Q1 | -5.49 Million USD | -189.28% |
| 2006 Q4 | -6.14 Million USD | -22.62% |
| 2006 FY | -17.49 Million USD | -84.67% |
| 2006 Q3 | -5.01 Million USD | 21.79% |
| 2006 Q2 | -6.41 Million USD | -16.67% |
| 2005 Q4 | 6.15 Million USD | 325.71% |
| 2005 FY | -9.47 Million USD | 50.32% |
| 2005 Q3 | -2.72 Million USD | 52.29% |
| 2005 Q2 | -5.71 Million USD | 35.67% |
| 2005 Q1 | -8.88 Million USD | 13.64% |
| 2004 Q4 | -10.28 Million USD | -287.24% |
| 2004 Q1 | -5.25 Million USD | -70.55% |
| 2004 FY | -19.06 Million USD | -10.4% |
| 2004 Q3 | -2.65 Million USD | 65.57% |
| 2004 Q2 | -7.71 Million USD | -46.77% |
| 2003 Q3 | -3.36 Million USD | 33.15% |
| 2003 FY | -17.27 Million USD | 23.9% |
| 2003 Q1 | -5.8 Million USD | -12.77% |
| 2003 Q2 | -5.02 Million USD | 13.34% |
| 2003 Q4 | -3.08 Million USD | 8.27% |
| 2002 Q3 | -6.71 Million USD | -22.14% |
| 2002 Q2 | -5.49 Million USD | -2.9% |
| 2002 Q4 | -5.14 Million USD | 23.37% |
| 2002 Q1 | -5.34 Million USD | -67.36% |
| 2002 FY | -22.69 Million USD | -132.91% |
| 2001 Q2 | -1.8 Million USD | 19.0% |
| 2001 Q1 | -2.23 Million USD | 55.24% |
| 2001 Q3 | -2.51 Million USD | -38.99% |
| 2001 FY | -9.74 Million USD | 20.06% |
| 2001 Q4 | -3.19 Million USD | -27.02% |
| 2000 Q2 | -2.64 Million USD | -95.63% |
| 2000 Q3 | -3.21 Million USD | -21.66% |
| 2000 Q4 | -4.98 Million USD | -55.21% |
| 2000 FY | -12.19 Million USD | -170.91% |
| 2000 Q1 | -1.35 Million USD | -35.0% |
| 1999 Q2 | -900 Thousand USD | 0.0% |
| 1999 Q4 | -1 Million USD | 44.44% |
| 1999 Q3 | -1.8 Million USD | -100.0% |
| 1999 Q1 | -900 Thousand USD | 43.75% |
| 1999 FY | -4.5 Million USD | 6.25% |
| 1998 Q2 | -1.2 Million USD | -50.0% |
| 1998 Q3 | -1.2 Million USD | 0.0% |
| 1998 Q4 | -1.6 Million USD | -33.33% |
| 1998 FY | -4.8 Million USD | -6.67% |
| 1998 Q1 | -800 Thousand USD | 20.0% |
| 1997 Q2 | -1.1 Million USD | 8.33% |
| 1997 Q3 | -1.1 Million USD | 0.0% |
| 1997 FY | -4.5 Million USD | 18.18% |
| 1997 Q4 | -1 Million USD | 9.09% |
| 1997 Q1 | -1.2 Million USD | 36.84% |
| 1996 Q3 | -1 Million USD | 28.57% |
| 1996 Q1 | -1.2 Million USD | 0.0% |
| 1996 Q4 | -1.9 Million USD | -90.0% |
| 1996 Q2 | -1.4 Million USD | -16.67% |
| 1996 FY | -5.5 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| BioNTech SE | 930.3 Million EUR | 158.59% |
| CureVac N.V. | -260.16 Million EUR | -109.505% |
| Biotest Aktiengesellschaft | 127 Million EUR | 529.183% |
| Biotest Aktiengesellschaft | 127 Million EUR | 529.183% |
| BRAIN Biotech AG | -8.27 Million EUR | -6483.67% |
| Formycon AG | 75.79 Million EUR | 819.127% |
| Heidelberg Pharma AG | -20.34 Million EUR | -2578.9% |
| Medigene AG | -16.17 Million EUR | -3269.364% |